Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Denali Therapeutics (DNLI) Other Gross PP&E Adjustments (2017 - 2026)

Denali Therapeutics has reported Other Gross PP&E Adjustments over the past 9 years, most recently at -$745000.0 for Q4 2025.

  • Quarterly Other Gross PP&E Adjustments fell 137.65% to -$745000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$745000.0 through Dec 2025, down 137.65% year-over-year, with the annual reading at -$745000.0 for FY2025, 137.65% down from the prior year.
  • Other Gross PP&E Adjustments was -$745000.0 for Q4 2025 at Denali Therapeutics, up from -$20.0 million in the prior quarter.
  • Over five years, Other Gross PP&E Adjustments peaked at $12.3 million in Q4 2023 and troughed at -$47.4 million in Q2 2025.
  • The 5-year median for Other Gross PP&E Adjustments is -$26.0 million (2023), against an average of -$20.2 million.
  • Year-over-year, Other Gross PP&E Adjustments skyrocketed 92.71% in 2023 and then plummeted 137.65% in 2025.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at $7.3 million in 2021, then decreased by 12.21% to $6.4 million in 2022, then skyrocketed by 92.71% to $12.3 million in 2023, then crashed by 83.93% to $2.0 million in 2024, then plummeted by 137.65% to -$745000.0 in 2025.
  • Per Business Quant, the three most recent readings for DNLI's Other Gross PP&E Adjustments are -$745000.0 (Q4 2025), -$20.0 million (Q3 2025), and -$47.4 million (Q2 2025).